Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences [GlobeNewswire] - NEW YORK -- Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver ... Today 05:01 AM
This news update brought to you by StockGoodies SizzlingStockPicks PennyStockTweets WallStreetSurfers and PennyStockMobsters. If there are stock news articles the board is missing that you would like included, please contact me. - P.R.
Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.